194 related articles for article (PubMed ID: 35569435)
1. The economic burden of overweight and obesity in Brazil: perspectives for the Brazilian Unified Health System.
Ferrari G; Giannichi B; Resende B; Paiva L; Rocha R; Falbel F; Rache B; Adami F; Rezende LFM
Public Health; 2022 Jun; 207():82-87. PubMed ID: 35569435
[TBL] [Abstract][Full Text] [Related]
2. The projected economic burden of non-communicable diseases attributable to overweight in Brazil by 2030.
Giannichi B; Nilson E; Ferrari G; Rezende LFM
Public Health; 2024 May; 230():216-222. PubMed ID: 38579649
[TBL] [Abstract][Full Text] [Related]
3. Economic burden of cancer attributable to overweight in the Brazilian Unified Health System.
de Carvalho JB; Giannichi B; Ferrari G; Tomita LY; Paiva LDS; Adami F; Rezende LFM
J Cancer Policy; 2022 Sep; 33():100345. PubMed ID: 35724958
[TBL] [Abstract][Full Text] [Related]
4. The costs of overweight and obesity-related diseases in the Brazilian public health system: cross-sectional study.
Bahia L; Coutinho ES; Barufaldi LA; Abreu Gde A; Malhão TA; de Souza CP; Araujo DV
BMC Public Health; 2012 Jun; 12():440. PubMed ID: 22713624
[TBL] [Abstract][Full Text] [Related]
5. Health system costs for individual and comorbid noncommunicable diseases: An analysis of publicly funded health events from New Zealand.
Blakely T; Kvizhinadze G; Atkinson J; Dieleman J; Clarke P
PLoS Med; 2019 Jan; 16(1):e1002716. PubMed ID: 30620729
[TBL] [Abstract][Full Text] [Related]
6. Burden of disease and direct costs to the health system attributable to high body mass index in Brazil.
Rocha LP; Machado ÍE; Fogal AS; Malta DC; Velasquez-Melendez G; Felisbino-Mendes MS
Public Health; 2024 Jun; 233():121-129. PubMed ID: 38870844
[TBL] [Abstract][Full Text] [Related]
7. Estimating the healthcare cost of overweight and obesity in South Africa.
Boachie MK; Thsehla E; Immurana M; Kohli-Lynch C; Hofman KJ
Glob Health Action; 2022 Dec; 15(1):2045092. PubMed ID: 35389331
[TBL] [Abstract][Full Text] [Related]
8. Cost of chronic kidney disease attributable to diabetes from the perspective of the Brazilian Unified Health System.
Goncalves GMR; Silva END
PLoS One; 2018; 13(10):e0203992. PubMed ID: 30273345
[TBL] [Abstract][Full Text] [Related]
9. The future costs of cancer attributable to excess body weight in Brazil, 2030-2040.
Rezende LFM; Malhão TA; da Silva Barbosa R; Schilithz AOC; da Silva RCF; Moreira LGM; Machado PAN; Arguelhes BP; Melo MELD
BMC Public Health; 2022 Jun; 22(1):1236. PubMed ID: 35729550
[TBL] [Abstract][Full Text] [Related]
10. Economic burden of colorectal and breast cancers attributable to lack of physical activity in Brazil.
Rezende LFM; Ferrari G; Bahia LR; Rosa RDS; da Rosa MQM; de Souza RC; Lee DH; Giovannucci E; Eluf-Neto J
BMC Public Health; 2021 Jun; 21(1):1190. PubMed ID: 34158014
[TBL] [Abstract][Full Text] [Related]
11. Health and economic burden of sugar-sweetened beverages consumption in Brazil.
Perelli L; Alcaraz A; Vianna CMM; Espinola N; Cairoli FR; Bardach A; Palacios A; Balan D; Johns P; Augustovski F; Pichón-Rivière A
Cad Saude Publica; 2023; 39(12):e00249422. PubMed ID: 38126558
[TBL] [Abstract][Full Text] [Related]
12. Costs of cancer attributable to excess body weight in the Brazilian public health system in 2018.
Corrêa Ferreira da Silva R; Bahia LR; Machado da Rosa MQ; Malhão TA; Mendonça EP; Rosa RDS; Araújo DV; Maya Moreira LG; Schilithz AOC; Diogenes Melo MEL
PLoS One; 2021; 16(3):e0247983. PubMed ID: 33705455
[TBL] [Abstract][Full Text] [Related]
13. Costs of obesity attributable to the consumption of sugar-sweetened beverages in Brazil.
da Silva BF; de Arruda Neta ADCP; de Alencar Rodrigues RE; de Araújo JM; Moreira PVL; Ferreira FELL; de Toledo Vianna RP; da Silva Neto JM; de Carli E; de Lima RLFC
Sci Rep; 2024 Jun; 14(1):13936. PubMed ID: 38886385
[TBL] [Abstract][Full Text] [Related]
14. Socioeconomic costs of overweight and obesity in Korean adults.
Kang JH; Jeong BG; Cho YG; Song HR; Kim KA
J Korean Med Sci; 2011 Dec; 26(12):1533-40. PubMed ID: 22147988
[TBL] [Abstract][Full Text] [Related]
15. Economic burden for the Unified Health System attributable to excessive sodium consumption in Brazil.
Guedes LFF; Vegi ASF; Felisbino-Mendes MS; Menezes MC; Meireles AL; Malta DC; Machado ÍE
Public Health; 2024 Mar; 228():178-185. PubMed ID: 38377832
[TBL] [Abstract][Full Text] [Related]
16. The macroeconomic burden of noncommunicable diseases associated with air pollution in China.
Chen S; Bloom DE
PLoS One; 2019; 14(4):e0215663. PubMed ID: 30998763
[TBL] [Abstract][Full Text] [Related]
17. [Economic costs of both overweight and obesity among Chinese urban and rural residents, in 2010].
Zhang J; Shi XM; Liang XF
Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Jun; 34(6):598-600. PubMed ID: 24125612
[TBL] [Abstract][Full Text] [Related]
18. The projected burden of non-communicable diseases attributable to overweight in Brazil from 2021 to 2030.
Nilson EAF; Gianicchi B; Ferrari G; Rezende LFM
Sci Rep; 2022 Dec; 12(1):22483. PubMed ID: 36577769
[TBL] [Abstract][Full Text] [Related]
19. Direct healthcare cost of obesity in brazil: an application of the cost-of-illness method from the perspective of the public health system in 2011.
de Oliveira ML; Santos LM; da Silva EN
PLoS One; 2015; 10(4):e0121160. PubMed ID: 25830909
[TBL] [Abstract][Full Text] [Related]
20. Modelling the effect of compliance with WHO salt recommendations on cardiovascular disease mortality and costs in Brazil.
Nilson EAF; Metlzer AB; Labonté ME; Jaime PC
PLoS One; 2020; 15(7):e0235514. PubMed ID: 32645031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
